https://pubmed.ncbi.nlm.nih.gov/26597972/
Our results do not support prior findings of larger effects in SC than MC trials addressing binary outcomes but show a very similar small increase in effect in...
subgroup analysissingle centersensitivitybasedvs
https://www.prnewswire.com/news-releases/subgroup-analysis-from-pivotal-wu-kong1b-study-exhibits-robust-efficacy-of-sunvozertinib-in-non-small-cell-lung-cancer-patients-with-egfr-exon-20-insertion-mutations-across-different-baseline-characteristics-302250031.html
/PRNewswire/ -- Dizal (SSE:688192), a biopharmaceutical company committed to developing novel medicines for the treatment of cancer and immunological...
subgroup analysispivotalwustudyexhibits